Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,361,282
  • Shares Outstanding, K 21,079
  • Annual Sales, $ 486,820 K
  • Annual Income, $ 18,780 K
  • 60-Month Beta 0.79
  • Price/Sales 2.84
  • Price/Cash Flow 10.22
  • Price/Book 3.10
Trade ANIP with:

Options Overview Details

View History
  • Implied Volatility 37.00% ( +3.92%)
  • Historical Volatility 17.44%
  • IV Percentile 28%
  • IV Rank 37.29%
  • IV High 62.08% on 08/04/23
  • IV Low 22.09% on 11/17/23
  • Put/Call Vol Ratio 1.38
  • Today's Volume 19
  • Volume Avg (30-Day) 202
  • Put/Call OI Ratio 12.70
  • Today's Open Interest 10,178
  • Open Int (30-Day) 8,758

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.77
  • Number of Estimates 3
  • High Estimate 0.81
  • Low Estimate 0.72
  • Prior Year 0.97
  • Growth Rate Est. (year over year) -20.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.20 +1.99%
on 04/19/24
70.81 -7.53%
on 03/25/24
-2.39 (-3.52%)
since 03/19/24
3-Month
53.69 +21.96%
on 01/29/24
70.81 -7.53%
on 03/25/24
+10.07 (+18.17%)
since 01/19/24
52-Week
36.99 +77.02%
on 04/26/23
70.81 -7.53%
on 03/25/24
+26.22 (+66.79%)
since 04/19/23

Most Recent Stories

More News
ANI: Q4 Earnings Snapshot

ANI: Q4 Earnings Snapshot

ANIP : 65.48 (+1.39%)
ANI: Q3 Earnings Snapshot

ANI: Q3 Earnings Snapshot

ANIP : 65.48 (+1.39%)
ANI: Q2 Earnings Snapshot

ANI: Q2 Earnings Snapshot

ANIP : 65.48 (+1.39%)
ANI Pharmaceuticals (ANIP) Beats Q1 Earnings and Revenue Estimates

ANI (ANIP) delivered earnings and revenue surprises of 244.12% and 28.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ANIP : 65.48 (+1.39%)
AYTU : 2.79 (unch)
ANI: Q1 Earnings Snapshot

ANI: Q1 Earnings Snapshot

ANIP : 65.48 (+1.39%)
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced business highlights and financial results for the three months ended March 31, 2023.

ANIP : 65.48 (+1.39%)
ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2023 financial results on Monday, May 8, 2023, prior to the market...

ANIP : 65.48 (+1.39%)
ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright...

ANIP : 65.48 (+1.39%)
ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Nitrofurantoin...

ANIP : 65.48 (+1.39%)
ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Colestipol...

ANIP : 65.48 (+1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 67.10
2nd Resistance Point 66.54
1st Resistance Point 65.56
Last Price 65.48
1st Support Level 64.01
2nd Support Level 63.45
3rd Support Level 62.47

See More

52-Week High 70.81
Last Price 65.48
Fibonacci 61.8% 57.89
Fibonacci 50% 53.90
Fibonacci 38.2% 49.91
52-Week Low 36.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar